| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, General Counsel | SVP, General Counsel
1 company
McGuire Annie is an EVP, General Counsel at VCYT. Recent filings cover 0 purchases and 17 sales. Those positions are worth an estimated $5.7M at current prices.
Our model assigns McGuire Annie a below-average insider score of 46/100, based on 7 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -6.9%.
McGuire Annie's largest disclosed position is in VCYT as EVP, General Counsel, worth about $5.7M. The recent filings there lean toward selling, a net 66,203 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | VCYT Veracyte, Inc. | EVP, General Counsel | Sell | 3,254 | $43.09 | $140,212.09 | -2.4% | - | - | |
| Jun 4, 2026 | VCYT Veracyte, Inc. | EVP, General Counsel | Sell | 3,176 | $49.76 | $158,035.98 | -2.3% | -10.1% | - | |
| May 6, 2026 | VCYT Veracyte, Inc. | SVP, General Counsel | Sell | 10,204 | $39.03 | $398,211.10 | -6.6% | +12.7% | - | |
| Mar 4, 2026 | VCYT Veracyte, Inc. | SVP, General Counsel | Sell | 6,658 | $35.55 | $236,724.83 | -6.6% | +31.9% | - | |
| Dec 16, 2025 | VCYT Veracyte, Inc. | SVP, General Counsel | Sell | 10,739 | $43.13 | $463,203.60 | -13.7% | -23.8% | - | |
| Dec 4, 2025 | VCYT Veracyte, Inc. | SVP, General Counsel | Sell | 1,422 | $47.30 | $67,260.78 | -1.8% | -23.5% | - | |
| Nov 5, 2025 | VCYT Veracyte, Inc. | SVP, General Counsel | Sell | 6,466 | $40.00 | $258,640.00 | -7.2% | -18.0% | - | |
| Oct 1, 2025 | VCYT Veracyte, Inc. | SVP, General Counsel | Sell | 2,160 | $35.00 | $75,607.56 | -2.4% | +16.8% | +22.0% | |
| Sep 19, 2025 | VCYT Veracyte, Inc. | SVP, General Counsel | Sell | 2,283 | $33.69 | $76,919.52 | -2.4% | +23.2% | +16.7% | |
| Mar 4, 2025 | VCYT Veracyte, Inc. | SVP, General Counsel | Sell | 1,142 | $33.69 | $38,476.49 | -1.6% | -21.6% | +6.3% |